Clinicopathological significance of PLAC1 expression in patients with bladder urothelial carcinoma

Dorafshan, Shima; Madjd, Zahra; Saeednejad Zanjani, Leili; Rahimi, Mandana; Safaei, Sadegh; Borumandnia, Nasrin; Zarnani, Amir-Hassan; Ghods, roya

Volume 15, Issue 2 (Int J Mol Cell Med 2026) Int J Mol Cell Med 2026, 15(2): 1434-1448 | Back to browse issues page

Mendeley

Zotero

RefWorks

Dorafshan S, Madjd Z, Saeednejad Zanjani L, Rahimi M, Safaei S, Borumandnia N, et al . Clinicopathological significance of PLAC1 expression in patients with bladder urothelial carcinoma. Int J Mol Cell Med 2026; 15 (2) :1434-1448
URL: http://ijmcmed.org/article-1-2741-en.html

Clinicopathological significance of PLAC1 expression in patients with bladder urothelial carcinoma

Shima Dorafshan¹

, Zahra Madjd²

, Leili Saeednejad Zanjani²

, Mandana Rahimi³

, Sadegh Safaei⁴

, Nasrin Borumandnia⁵

, Amir-Hassan Zarnani⁶

, Roya Ghods ^*⁷

1- Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran & Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
2- Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran
3- Hasheminejad Kidney Center, Pathology Department, Iran University of Medical Sciences (IUMS), Tehran, Iran
4- Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran & Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
5- Department of Epidemiology and Biostatistics, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran & Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
6- Department of Immunology, School of Public Health, Tehran University of Medical Sciences (TUMS), Tehran, Iran. & Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
7- Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran & Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran. , rghods77@yahoo.com

Abstract: (4 Views)

Ectopic expression of Placenta-specific 1 (PLAC1), a Cancer/Testis Antigen (CTA), was reported in various tumors, but its clinical relevance and prognostic value in bladder urothelial carcinoma (UC) remain unclear. This study evaluated PLAC1 expression in the membrane, cytoplasm, and nucleus of tumor cells and its clinicopathological significance in bladder UC patients. We analyzed 177 bladder UC samples to assess nuclear, cytoplasmic, and membranous PLAC1 expression by immunohistochemistry (IHC) on tissue microarrays (TMAs) and examined its associations with clinicopathological characteristics and prognosis. Higher cytoplasmic expression of PLAC1 was associated with increased histological grade (P< 0.001), advanced pathological primary tumor (pT) staging (P= 0.038), lamina propria involvement (P= 0.013), and lamina propria/muscularis (L/M) involvement (P= 0.038). A significant association was identified between the increased nuclear expression of PLAC1 and tumor size (P= 0.036) and higher histological grades (intensity of staining, P= 0.045). PLAC1 expression was not significantly associated with disease-specific survival (DSS) or progression-free survival (PFS) in bladder UC patients.
Cytoplasmic PLAC1 expression significantly correlates with higher tumor grade and advanced stage in bladder cancer, suggesting its potential as an exploratory biomarker. The association between PLAC1 expression and tumor invasiveness warrants further functional and prospective studies to clarify its biological significance.